Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1B Dose Escalating Study of the Safety, Short-Term Engraftment and Action of a Singly-Applied NB01 in Adults With Moderate Acne

NCT03450369 is registered in ClinicalTrials.gov with Naked Biome, Inc. as lead sponsor.

NCT NCT03450369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03450369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1B Dose Escalating Study of the Safety, Short-Term Engraftment and Action of a Singly-Applied NB01 in Adults With Moderate Acne
Lead sponsor
Naked Biome, Inc.
Phase
Phase 1
Overall status
Completed
Start date
January 24, 2018
Completion date
June 18, 2018
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris